Iowa SF2047 mandates a cap on cost-sharing for prescription insulin drugs at $25 per prescription.
Iowa SF2047 establishes a cap on the cost-sharing amount for prescription insulin drugs at $25 per prescription for up to a 31-day supply. This applies to various types of health insurance policies, including individual or group accident and sickness insurance, hospital or medical service contracts, health maintenance organization contracts, and plans for public employees. The bill allows insurers to reduce cost-sharing below $25 but mandates the cap at $25. The commissioner of insurance can adopt rules to administer these requirements.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.